Search

Your search keyword '"Siri Wang"' showing total 2 results
Start Over Author "Siri Wang" Journal bmj paediatrics open
2 results on '"Siri Wang"'

1. Does the EU’s Paediatric Regulation work for new medicines for children in Denmark, Finland, Norway and Sweden? A cross-sectional study

Author

Elin Kimland, Ann Marie Tötterman, Siri Wang, Pirkko Lepola, Ninna Gullberg, and Kirstine Moll Harboe

Subjects
Pediatrics, RJ1-570
Abstract

Objective The aim of this study was to assess the marketing status of the new paediatric medicinal products listed in the 10-year report as initially authorised between 2007 and 2016, reflecting the product availability in four Nordic countries.Design This is a cross-sectional study.Setting Analysis of the national medicine agency’s databases in Denmark, Finland, Norway and Sweden.Data source New medicinal products with paediatric indications and new paediatric formulations listed in the Annex of European Medicines Agency’s EU Paediatric Regulation 10-year report.Data analysis The products were classified according to national marketing status between January 2019 and March 2019, whether a product was authorised and whether the product was marketed.Main outcome measures The percentages of the new medicinal products with paediatric indications and new paediatric formulations having a valid marketing authorisation and being marketed, both in terms of the sums of all countries and separately for each country.Results Across the four countries, 21%–32% (16/76–24/76) of the new medicinal products were not marketed. Of the new formulations relevant to children, 29%–50% (16/56–28/56) were not marketed, and a significant proportion of these products had never been marketed.Conclusions This study reflects the reality of the implementation of the Paediatric Regulation. The results show that several new paediatric medicines and new formulations are not marketed. This affects the product availability. Similar data from other countries are needed to evaluate the overall European status to find remedies to current situation and increase the availability of the medicines for children.

Published
2020
Full Text
View/download PDF

2. Child modern slavery, trafficking and health: a practical review of factors contributing to children’s vulnerability and the potential impacts of severe exploitation on health

Author

Elin Kimland, Ann Marie Tötterman, Siri Wang, Pirkko Lepola, Ninna Gullberg, and Kirstine Moll Harboe

Subjects
Child abuse, medicine.medical_specialty, accident & emergency, media_common.quotation_subject, Vulnerability, Review, Safeguarding, Criminology, Health intervention, Pediatrics, RJ1-570, 03 medical and health sciences, 0302 clinical medicine, 030225 pediatrics, Intervention (counseling), medicine, 030212 general & internal medicine, media_common, children's rights, child Abuse, neurodevelopment, Public health, adolescent health, Pediatrics, Perinatology and Child Health, Psychology, Diversity (politics), Adolescent health
Abstract

Child trafficking is a form of modern slavery, a rapidly growing, mutating and multifaceted system of severe human exploitation, violence against children, child abuse and child rights violations. Modern slavery and human trafficking (MSHT) represents a major global public health concern with victims exposed to profound short-term and long-term physical, mental, psychological, developmental and even generational risks to health. Children with increased vulnerability to MSHT, victims (in active exploitation) and survivors (post-MSHT exploitation) are attending healthcare settings, presenting critical windows of opportunity for safeguarding and health intervention.Recognition of child modern slavery victims can be very challenging. Healthcare providers benefit from understanding the diversity of potential physical, mental, behavioural and developmental health presentations, and the complexity of children’s responses to threat, fear, manipulation, deception and abuse.Healthcare professionals are also encouraged to have influence, where possible, beyond the care of individual patients. Research, health insights, advocacy and promotion of MSHT survivor input enhances the collaborative development of evidence-based approaches to prevention, intervention and aftercare of affected children and families.

Published
2020

Catalog

Books, media, physical & digital resources
See catalog results